Innate Immune Responses to AAV Vectors.

Area of Science:

• Immunology
• Gene Therapy
• Virology

Background:

• Adeno-associated virus (AAV) vectors are promising for gene replacement therapy in genetic disorders.
• Immune responses, particularly from the innate immune system, can limit the efficacy of AAV gene therapy.
• Innate immunity plays a critical role in initial vector response and can trigger harmful adaptive immune reactions.

Purpose of the Study:

• To review recent discoveries concerning innate immune responses to adeno-associated virus (AAV) vectors.
• To discuss the role of the innate immune system in AAV gene therapy efficacy.
• To explore strategies for mitigating detrimental innate immune signaling pathways.

Main Methods:

• Review of current literature on AAV immunology and innate immune responses.
• Analysis of molecular pathways involved in AAV-mediated inflammation, including TLR9-MyD88 and NF-κB.
• Discussion of self-complementary AAV vector effects on immune activation.

Main Results:

• Innate immune responses, mediated by TLR9-MyD88 and NF-κB pathways, are critical in AAV vector recognition and inflammation.
• These pathways induce pro-inflammatory cytokines and type I interferon production.
• Self-complementary AAV vectors can exacerbate these inflammatory processes, while the alternative NF-κB pathway affects transgene expression.

Conclusions:

• Innate immune responses significantly impact AAV gene therapy outcomes.
• Targeting innate immune pathways, such as TLR9-MyD88 and NF-κB, is essential for improving AAV vector safety and efficacy.
• Further research into modulating these pathways could enhance therapeutic potential for genetic disorders.